Na+ stimulates binding of dopamine to the dopamine transporter in cells but not in cell-free preparations

被引:11
作者
Chen, NH [1 ]
Rickey, J [1 ]
Reith, MEA [1 ]
机构
[1] Univ Illinois, Coll Med, Dept Biomed & Therapeut Sci, Peoria, IL 61656 USA
关键词
binding; cocaine analog; dopamine transporter; sodium ion;
D O I
10.1046/j.1471-4159.2003.01889.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although Na+ is crucial for the function of the dopamine (DA) transporter (DAT), its role in the substrate binding step has been questioned. To address this issue, we investigated the effect of Na+ on DA binding by measuring the potency of DA in inhibiting the binding of the cocaine analogue [H-3]2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane (CFT) in intact cells expressing DAT in their plasma membranes and in membranes isolated from these cells. In cells, Na+ substantially enhanced the potency of DA in inhibiting CFT binding. This effect of Na+ was independent of buffer compositions and substitutes (sucrose vs. NMDG), more pronounced at 4degreesC than 25degreesC, and correlated with its stimulatory effect on DA uptake K-m. Removing extracellular Na+ had little effect on intracellular concentrations of Na+ and K+, or on membrane potential. These data suggest that extracellular Na+ most likely acts at the transporter level to enhance the binding of external DA during the transport cycle. In contrast, in cell-free membrane preparations the Na+ stimulation was abolished without impairment of the potency of DA in inhibiting CFT binding, regardless of whether sucrose was used to maintain the buffer osmolarity. The difference in Na+ dependence for DA to inhibit CFT binding between plasma membranes of intact cells and isolated membranes raises the possibility that intracellular ion environment, alone or in combination with other cellular factors, plays a critical role in determining DA-DAT interaction and the integration of Na+ modulation in this interaction.
引用
收藏
页码:678 / 686
页数:9
相关论文
共 25 条
[1]   NEUROTRANSMITTER TRANSPORTERS - RECENT PROGRESS [J].
AMARA, SG ;
KUHAR, MJ .
ANNUAL REVIEW OF NEUROSCIENCE, 1993, 16 :73-93
[2]   Neurotransmitter transporters as molecular targets for addictive drugs [J].
Amara, SG ;
Sonders, MS .
DRUG AND ALCOHOL DEPENDENCE, 1998, 51 (1-2) :87-96
[3]   EFFECTS OF SEVERAL CATIONS ON THE NEURONAL UPTAKE OF DOPAMINE AND THE SPECIFIC BINDING OF [H-3] GBR 12783 - ATTEMPTS TO CHARACTERIZE THE NA+ DEPENDENCE OF THE NEURONAL TRANSPORT OF DOPAMINE [J].
AMEJDKICHAB, N ;
BENMANSOUR, S ;
COSTENTIN, J ;
BONNET, JJ .
JOURNAL OF NEUROCHEMISTRY, 1992, 59 (05) :1795-1804
[4]   Biogenic amine transporters: regulation in flux [J].
Blakely, RD ;
Bauman, AL .
CURRENT OPINION IN NEUROBIOLOGY, 2000, 10 (03) :328-336
[5]  
CHEN N, 2002, NEUROTRANSMITTER TRA, P25
[6]   Cationic interactions at the human dopamine transporter reveal binding conformations for dopamine distinguishable from those for the cocaine analog 2α-carbomethoxy-3α-(4-fluorophenyl)tropane [J].
Chen, NH ;
Sun, LL ;
Reith, MEA .
JOURNAL OF NEUROCHEMISTRY, 2002, 81 (06) :1383-1393
[7]  
Chen NH, 1999, J PHARMACOL EXP THER, V290, P940
[8]   Transport-dependent accessibility of a cytoplasmic loop cysteine in the human dopamine transporter [J].
Chen, NH ;
Ferrer, JV ;
Javitch, JA ;
Justice, JB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (03) :1608-1614
[9]   The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis [J].
Chen, NH ;
Vaughan, RA ;
Reith, MEA .
JOURNAL OF NEUROCHEMISTRY, 2001, 77 (04) :1116-1127
[10]   Binding of uptake blockers to the neuronal dopamine transporter: further investigation about cationic and anionic requirements [J].
Corera, AT ;
Costentin, J ;
Bonnet, JJ .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2000, 362 (03) :213-221